Barrett Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $8.37M | Sell |
161,717
-6,316
| -4% | -$328K | 0.35% | 53 |
|
|
2021
Q4 | $9.92M | Buy |
168,033
+16,536
| +11% | +$819K | 0.37% | 52 |
|
|
2021
Q3 | $6.52M | Buy |
151,497
+1,667
| +1% | +$73.8K | 0.3% | 58 |
|
|
2021
Q2 | $5.87M | Sell |
149,830
-290
| -0.2% | -$11.3K | 0.27% | 60 |
|
|
2021
Q1 | $5.44M | Sell |
150,120
-6,124
| -4% | -$217K | 0.27% | 60 |
|
|
2020
Q4 | $5.75M | Sell |
156,244
-7,278
| -4% | -$267K | 0.3% | 57 |
|
|
2020
Q3 | $5.69M | Buy |
163,522
+27,979
| +21% | +$981K | 0.34% | 51 |
|
|
2020
Q2 | $4.21M | Buy |
135,543
+8,242
| +6% | +$280K | 0.27% | 57 |
|
|
2020
Q1 | $3.94M | Sell |
127,301
-1,827
| -1% | -$62.3K | 0.31% | 55 |
|
|
2019
Q4 | $4.8M | Buy |
129,128
+174
| +0.1% | +$6.2K | 0.29% | 61 |
|
|
2019
Q3 | $4.4M | Sell |
128,954
-4,906
| -4% | -$178K | 0.29% | 64 |
|
|
2019
Q2 | $5.5M | Sell |
133,860
-2,034
| -1% | -$80.8K | 0.36% | 55 |
|
|
2019
Q1 | $5.48M | Sell |
135,894
-1,299
| -0.9% | -$52K | 0.37% | 56 |
|
|
2018
Q4 | $5.68M | Buy |
137,193
+1,578
| +1% | +$65.5K | 0.44% | 55 |
|
|
2018
Q3 | $5.67M | Sell |
135,615
-4,549
| -3% | -$175K | 0.37% | 58 |
|
|
2018
Q2 | $4.83M | Sell |
140,164
-12,124
| -8% | -$414K | 0.33% | 62 |
|
|
2018
Q1 | $5.13M | Sell |
152,288
-2,496
| -2% | -$85.8K | 0.36% | 58 |
|
|
2017
Q4 | $5.32M | Buy |
154,784
+11,901
| +8% | +$406K | 0.37% | 57 |
|
|
2017
Q3 | $4.84M | Sell |
142,883
-25,602
| -15% | -$823K | 0.35% | 59 |
|
|
2017
Q2 | $5.37M | Buy |
168,485
+4,696
| +3% | +$148K | 0.41% | 56 |
|
|
2017
Q1 | $5.32M | Buy |
163,789
+482
| +0.3% | +$15.2K | 0.42% | 54 |
|
|
2016
Q4 | $5.03M | Buy |
163,307
+878
| +0.5% | +$26.8K | 0.42% | 55 |
|
|
2016
Q3 | $5.22M | Buy |
162,429
+4,120
| +3% | +$138K | 0.44% | 55 |
|
|
2016
Q2 | $5.29M | Buy |
158,309
+1,344
| +0.9% | +$42.9K | 0.46% | 55 |
|
|
2016
Q1 | $4.41M | Buy |
156,965
+27,306
| +21% | +$780K | 0.38% | 59 |
|
|
2015
Q4 | $3.97M | Sell |
129,659
-2,258
| -2% | -$71K | 0.35% | 61 |
|
|
2015
Q3 | $3.93M | Buy |
131,917
+1,223
| +0.9% | +$39.2K | 0.36% | 60 |
|
|
2015
Q2 | $4.16M | Sell |
130,694
-536
| -0.4% | -$17.5K | 0.34% | 63 |
|
|
2015
Q1 | $4.33M | Sell |
131,230
-8,076
| -6% | -$257K | 0.36% | 60 |
|
|
2014
Q4 | $4.12M | Buy |
139,306
+463
| +0.3% | +$13.3K | 0.32% | 67 |
|
|
2014
Q3 | $3.9M | Buy |
138,843
+2,804
| +2% | +$78.7K | 0.32% | 67 |
|
|
2014
Q2 | $3.83M | Sell |
136,039
-8,548
| -6% | -$244K | 0.31% | 67 |
|
|
2014
Q1 | $4.41M | Buy |
144,587
+10,135
| +8% | +$302K | 0.38% | 63 |
|
|
2013
Q4 | $3.91M | Sell |
134,452
-2,108
| -2% | -$61.4K | 0.35% | 65 |
|
|
2013
Q3 | $3.72M | Buy |
136,560
+948
| +0.7% | +$25.8K | 0.36% | 64 |
|
|
2013
Q2 | $3.6M | Buy |
+135,612
| New | +$3.75M | 0.37% | 63 |
|
Other funds holding PFE
Barrett Asset Management's PFE Position: Q1 2022 in Review
Barrett Asset Management reduced its Pfizer (PFE) stake by 3.8% in Q1 2022, selling an estimated $328K and leaving 161,717 shares worth $8.37M. The position accounts for 0.35% of the portfolio, ranked #53.
Barrett Asset Management first reported a position in PFE in Q2 2013 and has held it in 36 quarters since. The position peaked at $9.92M in Q4 2021. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.
- Barrett Asset Management held 161,717 shares of Pfizer worth $8.37M as of Q1 2022.
- Barrett Asset Management sold 6,316 Pfizer shares in Q1 2022, an estimated $328K.
- Pfizer made up 0.35% of Barrett Asset Management's portfolio in Q1 2022, its #53 holding.
- Barrett Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 36 quarters since.
- Barrett Asset Management's Pfizer position peaked at $9.92M in Q4 2021.
- 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.
Based on Barrett Asset Management's 13F filing for Q1 2022, filed 16 May 2022.